Dialysis of Drugs Guide im Vergleich zu OneView DPS Nutzung und Statistiken

The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs. Numerous literature sources have been used in preparing the guidelines. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies. In some cases, the available data may conflict. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis. For additional information on specific drugs, the reader should consult the primary literature. Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse. The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time. Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Apple App Store
Kostenlos
Medizin

Rang speichern

- -

OneView DPS

OneView Mobile: Designed and built for speed, efficiency, and streamlined data. When you’re balancing care for your patients being treated across multiple centers and hospitals, you need OneView. OneView enables DaVita-credentialed nephrologists to spend more time caring for their kidney patients and less time on administrative tasks. CAPABILITIES THAT MAKE YOUR LIFE EASIER Intuitive and straightforward to use, OneView helps you quickly access patient information and makes documentation seamless with: • Increased efficiency - workflows are simplified with all patient information on one screen instead of across platforms • Fast data - the app offers speed and efficiency for patient interactions from your mobile device • Timeline view - data in related treatment categories are presented in a timeline format, allowing more dedicated time with patients UNLOCK MORE FEATURES WITH ONEVIEW MOBILE • Document a Comprehensive or Limited encounter from your smartphone • Review your orders in a timely manner • View patients by facility, prioritized by the time remaining on dialysis • Access comments for patient care categories and treatment details quickly • Receive notifications for time-sensitive tasks • Login (optionally) with biometrics like Touch & Face Unlock • View medical records and accept or deny patient admission requests With our tools, user-friendly interface, and commitment to excellence, OneView Mobile is the clear choice for providers to streamline their workflow and help improve patient outcomes.